“…Indeed, certain genes upregulated in metaplastic corpus epithelium are highly expressed in antral glands at homeostasis, including DMBT1 ( Sousa et al, 2012 ; Garay et al, 2017 ) and GKN3 ( Menheniott et al, 2010 ; Bockerstett et al, 2020 ), but by the same token, various genes appear to be unique to metaplasia in the corpus, neither expressed in corpus nor antral glands at homeostasis. These include genes such as HE4 ( Jeong et al, 2021 ; Nozaki et al, 2008 ; O'Neal et al, 2013 ), CD44v9 ( Fan et al, 1996 ; Bertaux-Skeirik et al, 2015 ; Bertaux-Skeirik et al, 2017 ; Tsugawa et al, 2019 ), and CLU ( Weis et al, 2013 ; Shimizu et al, 2016 ) , among others ( Weis et al, 2014 ). A more appropriate term to describe these glandular changes (and which will be used in this review to refer to these metaplastic changes) is spasmolytic polypeptide-expressing metaplasia (or SPEM), which is characterized by the expression of the antral spasmolytic polypeptide in the bases of corpus glands ( Schmidt et al, 1999 ) and accurately describes the characteristic features of this metaplastic entity.…”